Literature DB >> 26185173

Dysregulation of shelterin factors coupled with telomere shortening in Philadelphia chromosome negative myeloproliferative neoplasms.

Jenny Dahlström1, Xiaolu Zhang1, Mehran Ghaderi2, Malin Hultcrantz1, Magnus Björkholm1, Dawei Xu3.   

Abstract

Entities:  

Keywords:  Philadelphia chromosome negative; dysregulation; myeloproliferative neoplasm; shelterin; telomere shortening

Mesh：

Substances：

Year:  2015        PMID： 26185173      PMCID： PMC4591775          DOI： 10.3324/haematol.2015.125765

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  No end in sight for telomerase-targeted cancer drugs.

Authors:  Sarah C P Williams
Journal:  Nat Med       Date:  2013-01       Impact factor: 53.440

Review 2.  Telomerase as a "stemness" enzyme.

Authors:  Feng Kong; ChengYun Zheng; DaWei Xu
Journal:  Sci China Life Sci       Date:  2014-05-15       Impact factor: 6.038

3.  Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.

Authors:  Thorsten Klampfl; Ashot Harutyunyan; Tiina Berg; Bettina Gisslinger; Martin Schalling; Klaudia Bagienski; Damla Olcaydu; Francesco Passamonti; Elisa Rumi; Daniela Pietra; Roland Jäger; Lisa Pieri; Paola Guglielmelli; Ilaria Iacobucci; Giovanni Martinelli; Mario Cazzola; Alessandro M Vannucchi; Heinz Gisslinger; Robert Kralovics
Journal:  Blood       Date:  2011-04-29       Impact factor: 22.113

4.  Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.

Authors:  Elisa Rumi; Francesco Passamonti; Matteo G Della Porta; Chiara Elena; Luca Arcaini; Laura Vanelli; Cecilia Del Curto; Daniela Pietra; Emanuela Boveri; Cristiana Pascutto; Mario Cazzola; Mario Lazzarino
Journal:  J Clin Oncol       Date:  2007-11-12       Impact factor: 44.544

Review 5.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

6.  Different expression levels of the telomerase catalytic subunit hTERT in myeloproliferative and myelodysplastic diseases.

Authors:  Oliver Bock; Ebru Serinsöz; Jerome Schlué; Hans Kreipe
Journal:  Leuk Res       Date:  2004-05       Impact factor: 3.156

Review 7.  Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.

Authors:  Ayalew Tefferi; Radek Skoda; James W Vardiman
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

8.  Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms.

Authors:  L Bernard; C Belisle; L Mollica; S Provost; D-C Roy; D G Gilliland; R L Levine; L Busque
Journal:  Leukemia       Date:  2008-11-13       Impact factor: 11.528

Review 9.  Telomere protein complexes and interactions with telomerase in telomere maintenance.

Authors:  Alexander Ruvantha Pinto; He Li; Craig Nicholls; Jun-Ping Liu
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

Review 10.  The telosome/shelterin complex and its functions.

Authors:  Huawei Xin; Dan Liu; Zhou Songyang
Journal:  Genome Biol       Date:  2008-09-18       Impact factor: 13.583
View more
  6 in total

1.  Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations.

Authors:  Samah Alimam; Donal P McLornan; Jie Jiang; Deepti Radia; Ghulam J Mufti; Claire N Harrison
Journal:  Haematologica       Date:  2017-11-30       Impact factor: 9.941

2.  Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.

Authors:  Xinyu Ci; Bingnan Li; Xueping Ma; Feng Kong; Chengyun Zheng; Magnus Björkholm; Jihui Jia; Dawei Xu
Journal:  Oncotarget       Date:  2015-11-10

Review 3.  Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells.

Authors:  Christine A Armstrong; Kazunori Tomita
Journal:  Open Biol       Date:  2017-03       Impact factor: 6.411

4.  TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.

Authors:  Jenny Dahlström; Tiantian Liu; Xiaotian Yuan; Leonie Saft; Mehran Ghaderi; Ya Bin Wei; Catharina Lavebratt; Ping Li; Chengyun Zheng; Magnus Björkholm; Dawei Xu
Journal:  Ann Hematol       Date:  2016-08-25       Impact factor: 3.673

5.  Telomere-related Markers for Cancer.

Authors:  Xiaotian Yuan; Mingkai Dai; Dawei Xu
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

6.  Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms.

Authors:  Matteo Giaccherini; Angelica Macauda; Nicola Sgherza; Juan Sainz; Federica Gemignani; Josè Manuel Sanchez Maldonado; Manuel Jurado; Francesca Tavano; Grzegorz Mazur; Andrés Jerez; Joanna Góra-Tybor; Aleksandra Gołos; Francisca Hernández Mohedo; Joaquin Martinez Lopez; Judit Várkonyi; Raffaele Spadano; Aleksandra Butrym; Federico Canzian; Daniele Campa
Journal:  Blood Cancer J       Date:  2020-09-01       Impact factor: 11.037
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.